CD2AP and Alzheimer disease: Since it is involved in maintaining the blood–brain barrier, both the inactivation and loss of function of CD2AP are thought to play a critical role in the pathogenesis of AD [74], which is consistent with the recent discovery of EOAD-associated variants [75].